Lessons from precision medicine in rheumatology

Area of Science:

• Rheumatology
• Immunology
• Genetics

Background:

• Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are common autoimmune rheumatic diseases with diverse clinical presentations and disease progression.
• Individual variability in SLE and RA necessitates advanced characterization for effective management.
• Molecular and genetic studies have begun to unravel the underlying pathways contributing to disease heterogeneity.

Purpose of the Study:

• To review key lessons learned regarding disease heterogeneity in rheumatology.
• To highlight the importance of molecular characterization for understanding autoimmune rheumatic diseases.
• To explore the potential for precision medicine approaches in treating SLE and RA.

Main Methods:

• Review of molecular and genetic studies in SLE and RA.
• Analysis of patient stratification based on molecular subsets.
• Synthesis of findings to inform personalized therapeutic strategies.

Main Results:

• Identification of molecular subsets within SLE and RA patients.
• Linkage of molecular pathways to disease outcomes and treatment responses.
• Demonstration of the feasibility of applying precision medicine in rheumatology.

Conclusions:

• Disease heterogeneity is a critical factor in SLE and RA.
• Molecular characterization is key to understanding and managing these diseases.
• Personalized therapeutic strategies hold promise for improving patient care in rheumatic diseases.